Mutual of America Capital Management LLC Sells 487 Shares of Colgate-Palmolive Company $CL

Mutual of America Capital Management LLC decreased its stake in Colgate-Palmolive Company (NYSE:CL) by 0.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 119,820 shares of the company’s stock after selling 487 shares during the period. Mutual of America Capital Management LLC’s holdings in Colgate-Palmolive were worth $10,892,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in CL. Price T Rowe Associates Inc. MD lifted its stake in Colgate-Palmolive by 18.3% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 34,009,078 shares of the company’s stock valued at $3,186,651,000 after purchasing an additional 5,269,140 shares during the last quarter. Nuveen LLC bought a new position in shares of Colgate-Palmolive during the first quarter valued at $217,593,000. Goldman Sachs Group Inc. raised its stake in shares of Colgate-Palmolive by 34.5% during the first quarter. Goldman Sachs Group Inc. now owns 7,980,387 shares of the company’s stock valued at $747,762,000 after acquiring an additional 2,045,191 shares during the last quarter. Diamond Hill Capital Management Inc. raised its stake in shares of Colgate-Palmolive by 45.0% during the first quarter. Diamond Hill Capital Management Inc. now owns 5,562,968 shares of the company’s stock valued at $521,250,000 after acquiring an additional 1,727,105 shares during the last quarter. Finally, Alliancebernstein L.P. raised its stake in shares of Colgate-Palmolive by 60.5% during the first quarter. Alliancebernstein L.P. now owns 2,336,783 shares of the company’s stock valued at $218,957,000 after acquiring an additional 880,527 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 1.4%

NYSE:CL opened at $79.14 on Monday. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. The stock has a market capitalization of $63.96 billion, a price-to-earnings ratio of 22.23, a PEG ratio of 4.64 and a beta of 0.34. The firm has a fifty day simple moving average of $81.96 and a two-hundred day simple moving average of $87.28. Colgate-Palmolive Company has a 12 month low of $76.68 and a 12 month high of $100.54.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, August 1st. The company reported $0.92 EPS for the quarter, topping analysts’ consensus estimates of $0.89 by $0.03. The business had revenue of $5.11 billion during the quarter, compared to analysts’ expectations of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The business’s quarterly revenue was up 1.0% on a year-over-year basis. During the same period last year, the company posted $0.91 earnings per share. Analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be issued a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date is Friday, October 17th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.43%.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on CL. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Colgate-Palmolive in a research note on Wednesday, October 8th. JPMorgan Chase & Co. dropped their price target on shares of Colgate-Palmolive from $95.00 to $88.00 and set an “overweight” rating for the company in a research note on Friday, October 10th. Bank of America decreased their price objective on shares of Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating for the company in a research report on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft set a $86.00 price objective on shares of Colgate-Palmolive in a research report on Friday, October 10th. Finally, Barclays decreased their price objective on shares of Colgate-Palmolive from $87.00 to $82.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 1st. Eight equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $92.21.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.